2020
DOI: 10.1016/j.hrtlng.2020.02.043
|View full text |Cite
|
Sign up to set email alerts
|

Biomarkers in atrial fibrillation and heart failure with non-reduced ejection fraction: Diagnostic application and new cut-off points

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(16 citation statements)
references
References 21 publications
0
14
0
2
Order By: Relevance
“…The 28 selected studies included a wide range of potential novel diagnostic HFpEF circulating biomarkers ( Table 1 ). 22–49 …”
Section: Resultsmentioning
confidence: 99%
“…The 28 selected studies included a wide range of potential novel diagnostic HFpEF circulating biomarkers ( Table 1 ). 22–49 …”
Section: Resultsmentioning
confidence: 99%
“…Beltrami, M. et al [26] 98 Gal3 was not able to distinguish between patients with HF with preserved or reduced LVEF. Merino-Merino, A. et al [27] 115 Gal3 was not related with HF in patients with AF.…”
Section: Demissei Bg Et Al [21] 1161mentioning
confidence: 91%
“…However, it is related to diastolic dysfunction severity and ventricular stiffness in patients with HF with preserved LVEF [26]. In this sense, our group has recently published a study including 115 patients with persistent nonvalvular AF, of which 87 (75.65%) presented HF criteria with nonreduced LVEF [27]. Differences in biomarkers (Gal3, ST2, urate, ultrasensitive troponin T, NT-proBNP, fibrinogen, and C-reactive protein (CRP)) were analyzed between patients with and without HF.…”
Section: St2 and Galectin-3 In Heart Failurementioning
confidence: 99%
“…It has grown to become the most prevalent form of HF, rising by 10% each decade with respect to its HFrEF counterpart [4]. Whilst the diagnosis can be challenging to make in certain circumstances, biomarker assessment of N-terminal pro-brain natriuretic peptide (NT-proBNP) is considered to have increased diagnostic accuracy in detecting HFpEF in AF patients [5]. There are many similarities in the pathophysiological mechanisms between these two conditions, with structural remodeling and fibrosis seen both in atrial and ventricular myocardium leading to changes in electrical conduction and diastolic dysfunction, respectively [6].…”
Section: Introductionmentioning
confidence: 99%